MiNK Therapeutics, Inc.INKTNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank83
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-12.16M
↑ 38% vs avg
Percentile
P83
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-19.50M
Historical baseline
PeriodValueYoY Change
TTM$-12.16M-15.0%
2024$-10.57M+52.5%
2023$-22.25M+20.2%
2022$-27.87M-0.6%
2021$-27.70M-101.6%
2020$-13.74M+38.1%
2019$-22.20M-